ERBB4-mediated signaling is a mediator of resistance to BTK and PI3K inhibitors in B cell lymphoid neoplasms
In: Cancer Weekly, 2023-01-17, S. 1158
Zeitungsartikel
Zugriff:
Titel: |
ERBB4-mediated signaling is a mediator of resistance to BTK and PI3K inhibitors in B cell lymphoid neoplasms
|
---|---|
Zeitschrift: | Cancer Weekly, 2023-01-17, S. 1158 |
Veröffentlichung: | 2023 |
Medientyp: | Zeitungsartikel |
ISSN: | 1532-4567 (print) |
Sonstiges: |
|